# American Institute of Mathematical Sciences

## Androgen driven evolutionary population dynamics in prostate cancer growth

 1 Department of Mathematics, Faculty of Science, King Abdulaziz University, P. O. Box 80203, Jeddah 21589, Saudi Arabia 2 Informetrics Research Group, Ton Duc Thang University, Ho Chi Minh City, Vietnam, and, Faculty of Mathematics and Statistics, Duc Thang University, Ho Chi Minh City, Vietnam

* Corresponding author: Muhammad Altaf Khan (muhammad.altaf.khan@tdtu.edu.vn)

Received  October 2019 Revised  January 2020 Published  September 2020

Prostate cancer worldwide is regarded the second most frequent diagnosed cancer in men with (899,000 new cases) while in common cancer it is the fifth. Regarding the treatment of progressive prostate cancer the most common and effective is the intermittent androgen deprivation therapy. Usually this treatment is effective initially at regressing tumorigenesis, mostly a resistance to treatment can been seen from patients and is known as the castration-resistant prostate cancer (CRPC), so there is no any treatment and becomes fatal. Therefore, we proposed a new mathematical model for the prostate cancer growth with fractional derivative. Initially, we present the model formulation in detail and then apply the fractional operator Atangana-Baleanu to the model. The fractional model will be studied further to analyze and show its existence of solution. Then, we provide a new iterative scheme for the numerical solution of the prostate cancer growth model. The analytical results are validated by considering various values assigned to the fractional order parameter $\alpha.$

Citation: Ebraheem O. Alzahrani, Muhammad Altaf Khan. Androgen driven evolutionary population dynamics in prostate cancer growth. Discrete & Continuous Dynamical Systems - S, doi: 10.3934/dcdss.2020426
##### References:

show all references

##### References:
The dynamics of the prostate cancer growth model with $\alpha = 1$
The dynamics of the prostate cancer growth model with $\alpha=0.98$
The dynamics of the prostate cancer growth model with $\alpha=0.96$
The dynamics of the prostate cancer growth model with $\alpha=0.9$
The dynamics of the prostate cancer growth model with $\alpha=0.8$
The dynamics of the prostate cancer growth model with $\alpha=0.7$
The dynamics of the prostate cancer growth model with $\alpha = 0.5$
Phase portraits of the model considering different variables with $\alpha = 1$
Phase portraits of the model considering different variables with $\alpha=0.98$
Phase portraits of the model considering different variables with $\alpha=0.96$
Phase portraits of the model considering different variables with $\alpha = 0.94$
Parameters and their values used in the model simulation.
 Parameter Description value Reference $\mu_m$ Maximum proliferation rate 0.025 day$^{-1}$ [5] $q_1, q_2$ Minimum AD and AI cell quota 0.175, 0.1 day$^{-1}$ [6] $\delta_1, \delta_2$ Androgen-independent rate 0.02 day$^{-1}$ [12] $d_1, d_2$ AD and AI cell apoptosis rate 0.015, 0.015 day$^{-1}$ [5] $c_1$ Mutation rate from AD to AI 0.00015 day$^{-1}$ [12] $c_2$ Mutation rate from AI to AD 0.0001 day$^{-1}$ [12] $q_m$ Cell maximum quota 5 day$^{-1}$ Assumed $\nu_m$ Uptake rate of the maximum cell quota 0.275 nM day$^{-1}$ Assumed $\nu_h$ Uptake rate half-saturation level 4 nM d Assumed $b$ Degradation rate of cell quota 0.09 day$^{-1}$ [12] $K_1$ Half-saturation level from AD to AI mutation 0.08 nM [12] $K_2$ Half-saturation level from AI to AD 1.7 nM [12] $R_1, R_2$ Androgen dependent rates 1.3, 0.8 Assumed $\gamma_1$ Androgen clearance rate 0.08 [12] $a_0$ Normal androgen concentration 10 [12] $\sigma_0$ Production rate of PSA 0.004 [12] $\sigma_1, \sigma_2$ AD and AI Production rate of PSA 0.05, 0.05 [12] $\varpi_1, \varpi_2$ Half saturation level of AD and AI PSA 1.3, 1.1 [12] $\delta_3$ PSA clearance rate 0.08 [12]
 Parameter Description value Reference $\mu_m$ Maximum proliferation rate 0.025 day$^{-1}$ [5] $q_1, q_2$ Minimum AD and AI cell quota 0.175, 0.1 day$^{-1}$ [6] $\delta_1, \delta_2$ Androgen-independent rate 0.02 day$^{-1}$ [12] $d_1, d_2$ AD and AI cell apoptosis rate 0.015, 0.015 day$^{-1}$ [5] $c_1$ Mutation rate from AD to AI 0.00015 day$^{-1}$ [12] $c_2$ Mutation rate from AI to AD 0.0001 day$^{-1}$ [12] $q_m$ Cell maximum quota 5 day$^{-1}$ Assumed $\nu_m$ Uptake rate of the maximum cell quota 0.275 nM day$^{-1}$ Assumed $\nu_h$ Uptake rate half-saturation level 4 nM d Assumed $b$ Degradation rate of cell quota 0.09 day$^{-1}$ [12] $K_1$ Half-saturation level from AD to AI mutation 0.08 nM [12] $K_2$ Half-saturation level from AI to AD 1.7 nM [12] $R_1, R_2$ Androgen dependent rates 1.3, 0.8 Assumed $\gamma_1$ Androgen clearance rate 0.08 [12] $a_0$ Normal androgen concentration 10 [12] $\sigma_0$ Production rate of PSA 0.004 [12] $\sigma_1, \sigma_2$ AD and AI Production rate of PSA 0.05, 0.05 [12] $\varpi_1, \varpi_2$ Half saturation level of AD and AI PSA 1.3, 1.1 [12] $\delta_3$ PSA clearance rate 0.08 [12]
 [1] Saif Ullah, Muhammad Altaf Khan, Muhammad Farooq, Ebraheem O. Alzahrani. A fractional model for the dynamics of tuberculosis (TB) using Atangana-Baleanu derivative. Discrete & Continuous Dynamical Systems - S, 2020, 13 (3) : 937-956. doi: 10.3934/dcdss.2020055 [2] Ilknur Koca. Numerical analysis of coupled fractional differential equations with Atangana-Baleanu fractional derivative. Discrete & Continuous Dynamical Systems - S, 2019, 12 (3) : 475-486. doi: 10.3934/dcdss.2019031 [3] Muhammad Bilal Riaz, Syed Tauseef Saeed. Comprehensive analysis of integer-order, Caputo-Fabrizio (CF) and Atangana-Baleanu (ABC) fractional time derivative for MHD Oldroyd-B fluid with slip effect and time dependent boundary condition. Discrete & Continuous Dynamical Systems - S, 2020  doi: 10.3934/dcdss.2020430 [4] G. M. Bahaa. Generalized variational calculus in terms of multi-parameters involving Atangana-Baleanu's derivatives and application. Discrete & Continuous Dynamical Systems - S, 2020, 13 (3) : 485-501. doi: 10.3934/dcdss.2020027 [5] Kashif Ali Abro, Ilyas Khan. MHD flow of fractional Newtonian fluid embedded in a porous medium via Atangana-Baleanu fractional derivatives. Discrete & Continuous Dynamical Systems - S, 2020, 13 (3) : 377-387. doi: 10.3934/dcdss.2020021 [6] T.L. Jackson. A mathematical model of prostate tumor growth and androgen-independent relapse. Discrete & Continuous Dynamical Systems - B, 2004, 4 (1) : 187-201. doi: 10.3934/dcdsb.2004.4.187 [7] Erica M. Rutter, Yang Kuang. Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer. Discrete & Continuous Dynamical Systems - B, 2017, 22 (3) : 1001-1021. doi: 10.3934/dcdsb.2017050 [8] M. M. El-Dessoky, Muhammad Altaf Khan. Application of Caputo-Fabrizio derivative to a cancer model with unknown parameters. Discrete & Continuous Dynamical Systems - S, 2020  doi: 10.3934/dcdss.2020429 [9] Badr Saad T. Alkahtani, Ilknur Koca. A new numerical scheme applied on re-visited nonlinear model of predator-prey based on derivative with non-local and non-singular kernel. Discrete & Continuous Dynamical Systems - S, 2020, 13 (3) : 429-442. doi: 10.3934/dcdss.2020024 [10] Jyoti Mishra. Analysis of the Fitzhugh Nagumo model with a new numerical scheme. Discrete & Continuous Dynamical Systems - S, 2020, 13 (3) : 781-795. doi: 10.3934/dcdss.2020044 [11] Alacia M. Voth, John G. Alford, Edward W. Swim. Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer. Mathematical Biosciences & Engineering, 2017, 14 (3) : 777-804. doi: 10.3934/mbe.2017043 [12] Harsh Vardhan Jain, Avner Friedman. Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy. Discrete & Continuous Dynamical Systems - B, 2013, 18 (4) : 945-967. doi: 10.3934/dcdsb.2013.18.945 [13] J. Ignacio Tello. On a mathematical model of tumor growth based on cancer stem cells. Mathematical Biosciences & Engineering, 2013, 10 (1) : 263-278. doi: 10.3934/mbe.2013.10.263 [14] Hsiu-Chuan Wei. Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer. Discrete & Continuous Dynamical Systems - B, 2016, 21 (4) : 1279-1295. doi: 10.3934/dcdsb.2016.21.1279 [15] Marzena Dolbniak, Malgorzata Kardynska, Jaroslaw Smieja. Sensitivity of combined chemo-and antiangiogenic therapy results in different models describing cancer growth. Discrete & Continuous Dynamical Systems - B, 2018, 23 (1) : 145-160. doi: 10.3934/dcdsb.2018009 [16] Tiffany A. Jones, Lou Caccetta, Volker Rehbock. Optimisation modelling of cancer growth. Discrete & Continuous Dynamical Systems - B, 2017, 22 (1) : 115-123. doi: 10.3934/dcdsb.2017006 [17] Michel H. Geoffroy, Alain Piétrus. A fast iterative scheme for variational inclusions. Conference Publications, 2009, 2009 (Special) : 250-258. doi: 10.3934/proc.2009.2009.250 [18] Azmy S. Ackleh, Mark L. Delcambre, Karyn L. Sutton, Don G. Ennis. A structured model for the spread of Mycobacterium marinum: Foundations for a numerical approximation scheme. Mathematical Biosciences & Engineering, 2014, 11 (4) : 679-721. doi: 10.3934/mbe.2014.11.679 [19] Elena Bonetti, Cecilia Cavaterra, Francesco Freddi, Maurizio Grasselli, Roberto Natalini. A nonlinear model for marble sulphation including surface rugosity: Theoretical and numerical results. Communications on Pure & Applied Analysis, 2019, 18 (2) : 977-998. doi: 10.3934/cpaa.2019048 [20] Krzysztof Frączek. Polynomial growth of the derivative for diffeomorphisms on tori. Discrete & Continuous Dynamical Systems - A, 2004, 11 (2&3) : 489-516. doi: 10.3934/dcds.2004.11.489

2019 Impact Factor: 1.233

## Metrics

• HTML views (53)
• Cited by (0)

## Other articlesby authors

• on AIMS
• on Google Scholar